Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2022-09-16

Clinical Trial Update: Nitrous Oxide for Pain Management During IUD Insertion in Nulliparous Adolescent Women [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial evaluating nitrous oxide for pain management during IUD insertion in nulliparous adolescent women was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nitrous oxide (nitrous oxide)

Snippet

Sponsor: Boston Children's Hospital | Conditions: Contraceptive Devices, Long-Acting Reversible Contraception | Phase 2, Phase 3 | Status: WITHDRAWN